Brazil HIV Drug Patent Ruling Allows Generics, Sends Pipeline Process Into Doubt
Word is spreading of a recent decision by a Brazilian judge to annul a patent on a key AIDS drug, effectively allowing less expensive generic versions into the country, and calling into question other such patents.
